SB-120 shows promising efficacy and excellent safety in clinical trials for ABC. Scutellaria barbata selectively targets C cell mitochondria and is distinguished by its ability to induce not only inhibition of OXPHOS but also of glycolysis.*
*These statements have not been evaluated by the Food and Drug Administration (FDA). These products are not intended to diagnose, treat, cure or prevent any disease
